Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Testicular cancer treatment: does surgery beat chemo for quality of life?

NCT ID NCT07498959

First seen Apr 12, 2026 · Last updated Jun 19, 2026 · Updated 15 times

Summary

This study follows 160 men with good-prognosis metastatic testicular cancer to see whether surgery (RPLND) or chemotherapy leads to a better quality of life. Participants choose their treatment, and researchers track side effects, fatigue, and overall well-being over time. The goal is to find out which approach causes fewer long-term problems.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for QUALITY OF LIFE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Sahlgrenska University Hospital

    RECRUITING

    Gothenburg, Göteborg, 413 45, Sweden

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

primary retroperitoneal lymph node dissection (RPLND) or chemotherapy (bleomycin, etoposide, platinum)

What this could lead to

If this study shows that surgery causes fewer side effects than chemotherapy, it could lead to a change in standard treatment for some men with testicular cancer.

What could go wrong

This is an observational study, not a controlled trial, so results may be less definitive. The findings may not apply to all patients or cancer stages.

Conditions

The condition(s) this trial relates to.

seminoma testicular cancer testicular non-seminomatous germ cell tumor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.